Fides Pharma
Hyderabad, India· Est.
Indian biotech company developing diagnostic tools, molecular biology kits, and research services across oncology, immunology, and metabolic diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian biotech company developing diagnostic tools, molecular biology kits, and research services across oncology, immunology, and metabolic diseases.
OncologyImmunologyMetabolic DiseasesNeurology
Technology Platform
The company utilizes molecular biology and genomic technologies including PCR/qPCR, ELISA, and biomarker analysis platforms for diagnostic and research applications.
Opportunities
Growing demand for molecular diagnostics in India and emerging markets, plus potential expansion into cell therapies and innovative treatments for chronic diseases.
Risk Factors
Limited pipeline visibility, potential competition from established diagnostic companies, and unclear differentiation in crowded biotechnology services market.
Competitive Landscape
Competes with diagnostic companies like Thermo Fisher and Qiagen in reagents/kits, and Indian biotech service providers; differentiation through integrated diagnostic-research-therapeutic approach remains unproven.